Identification of pyroptosis related genes and subtypes in atherosclerosis using multiomic and single cell analysis.

Journal: Scientific reports
Published Date:

Abstract

Atherosclerosis (AS), the leading cause of cardiovascular diseases, is a chronic inflammatory disorder involving lipid metabolism, immune dysregulation, and cell death. Pyroptosis, a form of inflammatory programmed cell death, is implicated in AS progression, yet its molecular mechanisms and therapeutic potential remain incompletely understood. A multi-omics framework integrating transcriptomics, single-cell RNA sequencing, and machine learning to identify and prioritize pyroptosis-related genes (PRGs) in AS. Functional enrichment, immune infiltration profiling, and protein-protein interaction network analyses were conducted. Experimental validation was conducted using in vitro and in vivo models. Thirty-six PRGs were identified, with TREM2, TNF, MMP9, IL1B, and CASP1 emerging as key regulators of pyroptosis and inflammation. These PRGs demonstrated robust diagnostic potential in internal and external datasets. Immune infiltration analysis stratified AS patients into subtypes, with Cluster 2 characterized by elevated macrophage pyroptosis and a pro-inflammatory immune microenvironment. Single-cell analysis confirmed TREM2 upregulation in macrophages and monocytes, linking it to immune activation and plaque instability. Experimental validation revealed TREM2's dual role in promoting macrophage lipid accumulation and pyroptosis. This study establishes PRGs, particularly TREM2, as critical modulators of AS progression. These findings enhance our understanding of pyroptosis in AS and provide a framework for developing PRG-based diagnostic and therapeutic strategies.

Authors

  • Kaisheng Jiang
    Faculty of Forensic Medicine, Guangdong Province Translational Forensic Medicine Engineering Technology Research Center, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, People's Republic of China.
  • Yang He
    Department of Emergency Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhenjiang Province, China.
  • Bingjie Hu
    Division of Forensic Medicine, Department of Pathology, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, 511436, People's Republic of China.
  • Li Quan
    Beijing Municipal Key Laboratory of Child Development and Nutriomics, Capital Institute of Pediatrics, Beijing 100020, China; Institute of Molecular Medicine, Peking University, Beijing 100871, China. Electronic address: li_quan@pku.edu.cn.
  • Longyun Peng
    Department of Cardiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, People's Republic of China.
  • Juntao Tian
    Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, People's Republic of China.
  • Nan Zhou
    Department of Radiology, the Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China.
  • Erwen Huang
    Faculty of Forensic Medicine, Guangdong Province Translational Forensic Medicine Engineering Technology Research Center, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 510080, People's Republic of China. huangerw@mail.sysu.edu.cn.
  • Qianhao Zhao
    Department of Human Anatomy, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China. zhaoqh@gzucm.edu.cn.